XML 64 R11.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value Measurement
9 Months Ended
Dec. 28, 2014
Fair Value Disclosures [Abstract]  
Fair Value Measurement
Fair Value Measurement
The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of December 28, 2014:
 
Fair Value at Reporting Date Using
(in thousands)
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
 
Total
Cash Equivalents and Short-Term Investments:
 
 
 
 
 
 
 
US government treasuries and agencies securities
$
118,987

 
$

 
$

 
$
118,987

Money market funds
62,968

 

 

 
62,968

Asset-backed securities

 
26,076

 

 
26,076

Corporate bonds

 
208,327

 

 
208,327

International government bonds

 
1,001

 

 
1,001

Corporate commercial paper

 
11,394

 

 
11,394

Bank deposits

 
13,667

 

 
13,667

Repurchase agreement

 
194

 

 
194

Municipal bonds

 
7,014

 

 
7,014

Total assets measured at fair value
$
181,955

 
$
267,673

 
$

 
$
449,628


The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of March 30, 2014:
 
Fair Value at Reporting Date Using
 
 
 
(in thousands)
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
 
Total
Cash Equivalents and Short-Term Investments:
 
 
 
 
 
 
 
US government treasuries and agencies securities
$
112,253

 
$

 
$

 
$
112,253

Money market funds
53,430

 

 

 
53,430

Asset-backed securities

 
22,332

 

 
22,332

Corporate bonds

 
199,806

 

 
199,806

International government bonds

 
3,014

 

 
3,014

Corporate commercial paper

 
6,246

 

 
6,246

Bank deposits

 
18,538

 

 
18,538

Repurchase agreements

 
46

 

 
46

Municipal bonds

 
9,210

 

 
9,210

Total assets measured at fair value
$
165,683

 
$
259,192

 
$

 
$
424,875

Liabilities:
 
 


 
 
 
 
Fair value of contingent consideration

 

 
2,140

 
2,140

Total liabilities measured at fair value
$

 
$

 
$
2,140

 
$
2,140



U.S. government treasuries and U.S. government agency securities as of December 28, 2014 and March 30, 2014 do not include any U.S. government guaranteed bank issued paper. Corporate bonds include bank-issued securities that are guaranteed by the Federal Deposit Insurance Corporation (FDIC).
The securities in Level 1 are highly liquid and actively traded in exchange markets or over-the-counter markets. Level 2 fixed income securities are priced using quoted market prices for similar instruments, non-binding market prices that are corroborated by observable market data.
In connection with the acquisition of Alvand Technologies in fiscal 2013, a liability was recognized for the Company’s estimate of the fair value of contingent consideration on the acquisition date based on probability-based forecasted revenues, gross profits and attainment of product development milestones. These fair value measurements are based on significant inputs not observed in the market and thus represent a Level 3 measurement, which reflect the Company’s own assumptions concerning future revenues, gross profit and product development milestones of the acquired businesses in measuring fair value.
The following table summarizes the change in the fair value of the contingent consideration measured using significant unobservable inputs (Level 3) for the nine months ended December 28, 2014:
(in thousands)
Estimated Fair Value
Balance as of March 30, 2014
$
2,140

Payment, net of fair value adjustments
(1,600
)
Release
(540
)
Balance as of December 28, 2014
$



During the first quarter of fiscal 2015, the Company paid $1.6 million and released the remaining contingent consideration of $0.5 million to discontinued operations, as the remaining future milestones were not achieved as a result of the sale of certain assets related to the Alvand portion of the HSC business.

All of the Company’s available-for-sale investments are subject to a periodic impairment review. Investments are considered to be impaired when a decline in fair value is judged to be other-than-temporary. The Company did not record any impairment charges related to its available-for-sale investments in the nine months ended December 28, 2014 and December 29, 2013.